Koa Labs

What is Koa Labs?

Koa Labs is a venture capital firm based in Harvard Square, Cambridge, MA, specializing in early-stage and seed investments.

With a dedication to uplifting underrepresented entrepreneur communities, they focus primarily on female, immigrant, and BIPOC founders. The firm has a strong preference for health-tech startups and seeks to nurture the ecosystem of entrepreneurs based in Boston.

They aim to empower first-time entrepreneurs by offering financial support ranging from $50,000 to $250,000. On their website, Koa Labs highlights their commitment to supporting entrepreneurs who follow their passion. Their impressive portfolio showcases involvement with over 200 founders across more than 130 investments, contributing to over 20 affiliate funds, and having helped foster at least 4 unicorn companies.

They underline their impact by disclosing a $14M investment into startups with over 80 founders from underserved communities. Koa Labs offers a glimpse of their successful investments with companies acquired by high-profile entities such as Smart Eye, WebMD, Twitter, Thomas H.

Lee Partners, Allscripts, Verizon, IBM, CyberArk, Salesforce, HealthTap, Databricks, Bain Capital, Amazon, Insight Partners, HubSpot, Splunk, and Athenahealth. Koa Labs also proudly mentions portfolio companies that have gone public such as NYSE: DM, NYSE: FIGS, and NASDAQ: FMTX, and celebrates female and immigrant founders' achievements within their investments.

The firm's co-investors include renowned venture capital funds and organizations such as Accomplice, Alumni Ventures, Andreessen Horowitz, Argon Ventures, Boston Seed Capital, Eric Schmidt, Founder Collective, Google Ventures, Gutbrain Ventures, Kepha Partners, Khosla Ventures, Kleiner Perkins, Lux Capital, MassChallenge, New Enterprise Associates (NEA), PBJ Capital, Pillar, Raptor Ventures, Sigma Prime Ventures, and TechStars.

What they say:

We invest in first-time entrepreneurs from undeserved entrepreneur communities (female, immigrant, & BIPOC founders)with a preference to health-tech startups and the Boston-founder ecosystem.